ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Fulcrum

NEW YORK, May 13, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminded purchasers of securities of Fulcrum Therapeutics Inc., (NASDAQ: FULC) between March 3, 2022 and March 8, 2023, both dates inclusive (the “Class Period”), of the important June 27, 2023 lead plaintiff deadline. SO WHAT: If you […]

Continue Reading

Final FTC Rule on Non-Competing Not Expected Before April 2024

According to Bloomberg, The Federal Trade Commission (“FTC”) is not expected to vote on the final version of a new rule that would ban non-compete clauses in employment contracts until April 2024. The rule defines a “non-compete clause” as “ a contractual term between an employer and a worker that prevents the worker from seeking […]

Continue Reading

Harmony Biosciences Holdings: Company Investigated by the

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, March 29, 2023 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Harmony Biosciences Holdings, Inc. (“Harmony Biosciences” or the “Company”) (NASDAQ: HRMY) investors that the firm has initiated an investigation into possible securities fraud and may file […]

Continue Reading

FTC Commissioner Christine Wilson, the Lone Dissenting Voice on the FTC’s Proposed Noncompete Ban, Resigns

FTC Commissioner Christine Wilson, published an Op-Ed in the Wall Street Journal today in which she announced her resignation from the FTC and explained her reasoning. Readers may recall that Commissioner Wilson was the lone dissenting voice on the FTC’s proposed banning rule non-competes nationwide. In the Op-Ed, Commissioner Wilson says that her decision to […]

Continue Reading